Prospective evaluation of allergen-component resolved diagnostic allergy testing and its relation to clinical features of allergic disease in childre

• Conditions: allergic disease; allergy; 10001708

• Registration Number: NL-OMON38409
• Lead Sponsor: Isala Klinieken

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 1000

Inclusion Criteria

- each child (0-17 years of age) referred (by general practitioner or hospital-based medical specialist) to the Isala laboratory for allergy testing
- written informed consent from parents/caregivers

Exclusion Criteria

- no parental consent

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>relationship between component resolved diagnostics (specific IgE against<br /><br>components of major inhalant and food allergens) and symptoms of allergic<br /><br>disease in children (atopic dermatitis, asthma, allergic rhinitis, and food<br /><br>allergy)</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>